IP Library Granted Patent US 8,962,565
Granted Patent B2
US 8,962,565 · App. 13/982,386 · Granted Feb 24, 2015

Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,962,565
App. No.
13/982,386
Granted
Feb 24, 2015
Kind
B2
Abstract

Peptide compounds of general formula (I) R 1 -(AA) n -X 1 —X 2 —X 3 -Asp-Leu-Lys-Lys-X 4 —X 5 -(AA) p -R 2 , cosmetic or pharmaceutical compositions comprising at least one peptide compound of general formula (I) in a physiologically acceptable medium, and methods for cosmetic treatment of skin are disclosed. The peptide compounds of general formula (I) were demonstrated to be agents making it possible to influence the pigmentation of the skin and skin appendages, by ensuring optimal transfer of the melanosomes to the keratinocytes, so as to make the skin tone uniform owing to an effect on the SCF/c-Kit signaling pathway. The compounds, compositions, and methods treat or attenuate age-related pigmentation defects and the effects of photoaging on the skin.

Claims (57)

1. A peptide compound having one of the following sequences selected from the group consisting of:

(SEQ ID NO: 1)

Ser-Cys-Arg-Asp-Leu-Lys-Lys-Thr-NH 2 ;

(SEQ ID NO: 2)

Asn-Ser-Ser-Lys-Asp-Leu-Lys-Lys-Phe-Val-Ala-NH 2

(SEQ ID NO: 3)

Cys-Lys-Asp-Leu-Lys-Lys-Ser-Phe;

(SEQ ID NO: 4)

Gln-Thr-Arg-Asp-Leu-Lys-Lys-Ser-Pro-Lys-Val-NH 2 ;

(SEQ ID NO: 5)

Asn-Lys-Asp-Leu-Lys-Lys-Pro-Met;

(SEQ ID NO: 6)

His-Asp-Leu-Lys-Lys-Tyr-NH 2 ; 

or

(SEQ ID NO: 7)

Asp-Leu-Lys-Lys-NH 2 .

2. The peptide compound of claim 1 , wherein the peptide compound is solubilized in one or more physiologically acceptable solvents, selected from the group consisting of water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, and mixtures thereof.

3. A cosmetic composition comprising: a peptide compound, as an active principle, selected from the group consisting of:

(SEQ ID NO: 1)

Ser-Cys-Arg-Asp-Leu-Lys-Lys-Thr-NH 2 ;

(SEQ ID NO: 2)

Asn-Ser-Ser-Lys-Asp-Leu-Lys-Lys-Phe-Val-Ala-NH 2 ;

(SEQ ID NO: 3)

Cys-Lys-Asp-Leu-Lys-Lys-Ser-Phe;

(SEQ ID NO: 4)

Gln-Thr-Arg-Asp-Leu-Lys-Lys-Ser-Pro-Lys-Val-NH 2 ;

(SEQ ID NO: 5)

Asn-Lys-Asp-Leu-Lys-Lys-Pro-Met;

(SEQ ID NO: 6)

His-Asp-Leu-Lys-Lys-Tyr-NH 2 ;

(SEQ ID NO: 7)

Asp-Leu-Lys-Lys-NH 2 ;

and combinations thereof.

4. The composition of claim 3 , wherein the composition is a topical composition comprising a cosmetically acceptable medium.

5. The composition of claim 3 , wherein said peptide compound is present in the composition at a concentration of between around 0.0005 and 500 parts per million (ppm).

6. The composition of claim 5 , further comprising at least one other active principle agent selected from the group consisting of plant peptide hydrolysates, other peptide compounds, sunscreens, anti-free radical agents, anti-wrinkle agents, and combinations thereof.

7. A method for cosmetic treatment of skin, the method comprising:

applying a composition comprising: a peptide compound, as an active principle, having one of the following sequences selected from the group consisting of:

(SEQ ID NO: 1) Ser-Cys-Arg-Asp-Leu-Lys-Lys-Thr-NH 2 ;

(SEQ ID NO: 2) Asn-Ser-Ser-Lys-Asp-Leu-Lys-Lys-Phe-Val-Ala-NH 2

(SEQ ID NO: 3) Cys-Lys-Asp-Leu-Lys-Lys-Ser-Phe;

(SEQ ID NO: 4) Gln-Thr-Arg-Asp-Leu-Lys-Lys-Ser-Pro-Lys-Val-NH 2 ;

(SEQ ID NO: 5) Asn-Lys-Asp-Leu-Lys-Lys-Pro-Met;

(SEQ ID NO: 6) His-Asp-Leu-Lys-Lys-Tyr-NH 2 ; or

(SEQ ID NO: 7) Asp-Leu-Lys-Lys-NH 2 , and combinations thereof, and

a cosmetically acceptable medium.

8. The method of claim 7 , wherein applying the composition comprises the application of a protective layer on the skin acting against ultraviolet (UV) radiation.

9. The method of claim 7 comprising treating age-related pigmentation defects and the effects of photoaging on the skin.

10. The method of claim 9 , wherein the age-related pigmentation defects comprise age spots, solar lentigines, depigmentation spots, or freckles.

11. The method of claim 7 comprising treating skin tone irregularities and unifying skin tone.

12. The method of claim 7 , wherein applying the composition comprises a morning application and an evening application.

13. The method of claim 7 , wherein applying the composition comprises a before sun exposure application thereof, as before-sun care, or an after sun exposure application thereof, as after-sun care.

14. The composition of claim 3 , wherein the peptide compound is solubilized in one or more physiologically acceptable solvents, selected from the group consisting of water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, and mixtures thereof.

15. The composition of claim 3 , wherein said peptide compound is present in the composition at a concentration of between around 0.01 and 5 parts per million (ppm).

16. The method of claim 7 , wherein the cosmetic treatment further comprises attenuating age-related pigmentation defects and the effects of photoaging on the skin.

17. The method of claim 7 , wherein the skin has age-related pigmentation defects.

18. The method of claim 7 , wherein the skin has premature aging caused by exposure to the sun.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2013
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 030900/0149 →